REG - AstraZeneca PLC - Notice of AGM

AstraZenecaAnnouncement

13/04/2018 11:00

RNS Number : 8702K
AstraZeneca PLC
13 April 2018
 

13 April 2018 11:00 BST
 
NOTICE OF ANNUAL GENERAL MEETING
 
AstraZeneca PLC (the Company) announced today the publication of its Notice of Annual General Meeting 2018 and Shareholders' Circular (the Notice).
 
The Notice has been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm. The Notice is also available on the Company's website at www.astrazeneca.com/agm.
 
The Company's Annual Report and Form 20-F Information 2017 was published on 6 March 2018.
 
The Notice is being despatched to shareholders today.
 
The meeting place for the Annual General Meeting (AGM) will be the Royal Lancaster London Hotel, Lancaster Terrace, London W2 2TY and the AGM will commence at 2.30 pm (BST) on 18 May 2018.
 
 
About AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. 
 
For more information, please visit www.astrazeneca.com and follow us on Twitter @AstraZeneca.
 




Media Relations












Esra Erkal-Paler


UK/Global


+44 203 749 5638




Karen Birmingham


UK/Global


+44 203 749 5634




Rob Skelding


UK/Global


+44 203 749 5821




Matt Kent


UK/Global


+44 203 749 5906




Gonzalo Viña


UK/Global


+44 203 749 5916




Jacob Lund


Sweden


+46 8 553 260 20




Michele Meixell


US


+1 302 885 2677


















Investor Relations












Thomas Kudsk Larsen


 
 


+44 203 749 5712




Craig Marks


Finance; Fixed Income; M&A


+44 7881 615 764




Henry Wheeler


Oncology


+44 203 749 5797




Mitchell Chan


Oncology; Other


+1 240 477 3771




Christer Gruvris


Brilinta; Diabetes


+44 203 749 5711




Nick Stone


Respiratory; Renal


+44 203 749 5716




US toll free






+1 866 381 7277




 
Adrian Kemp

Company Secretary
AstraZeneca PLC
 



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOAGGUQWCUPRUBW